Search results for: Determining Value
Filter search results
Multi-indication Pricing: Pros, Cons and Applicability to the UK
28 October 2015
…different price for each major indication approved for a medicine. As value is likely to differ across major indications, if prices paid for on-patent medicines are to reflect their value,…
New Publication: Headroom Approach to Device Development
23 February 2016
OHE’s Amanda Cole co-authors a new publication on the headroom approach, which can help assess the commercial value and viability of medical device development. In the latest issue of the…
Open Source Modelling: From Ideas to Action
16 May 2022
OHE’s Chris Sampson is currently Chair of the ISPOR Open Source Models Special Interest Group (SIG). The SIG recently published their first journal article in Value in Health and will…
Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB
24 March 2022
…A. (2020). Blueprint for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Center for Global Development. Available at: https://www.cgdev.org/publication/blueprint-market-driven-value-based-advance-commitment-tuberculosis Chalkidou, K., Towse, A., Silverman, R., Garau, M., Ramakrishnan, G., 2020….
Analysing Global Immunisation Expenditure
15 April 2025
…of healthcare expenditure. The current magnitude of spending may be too low given the growing evidence of the societal and economic value that successfully implemented immunisation programs can deliver. Coverage…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
…(2020) Blueprint for a Market-Driven value-based advance commitment (MVAC) for tuberculosis. Center for Global Development and the Office of Health Economics. Available: https://www.cgdev.org/publication/blueprint-market-driven-value-based-advance-commitment-tuberculosis Chalkidou K, Towse A, Silverman R, et…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…is the issue? The price we pay for medicines should: be aligned with the value medicines provide to patients and the health service; be affordable; and offer a fair reward…
We Asked, You Answered: Reflections on the First Round of MVAC Feedback
16 May 2019
Market-Driven, Value-Based Advanced Commitment (MVAC) is a new mechanism to help re-direct private-sector R&D investments where they’re needed most. We propose to use MVAC to encourage investments in tuberculosis (TB),…
OHE at ISPOR Boston 2017: Presentations and Posters
4 July 2017
…Patient-Centered Value Frameworks: But, in what direction? The panel explored different perspectives on the way that patients’ preferences and views could best be incorporated into value frameworks. Nancy argued that…